Press Releases

01.13.2020
Iveric Bio Announces Design for Second Pivotal Clinical Trial of Zimura® in Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
12.19.2019
Iveric Bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA
12.19.2019
Iveric Bio to Present at the 38th Annual J.P. Morgan Healthcare Conference
12.06.2019
Iveric Bio Announces Pricing of Public Offering of Common Stock
12.05.2019
Iveric Bio Announces Proposed Offering of Common Stock
11.26.2019
Iveric Bio to Present at Evercore ISI 2nd Annual HealthCONx Conference
11.25.2019
Iveric Bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapy
11.14.2019
Iveric Bio to Host a Zimura® R&D Symposium for Investors / Analysts on November 20, 2019
11.12.2019
Iveric Bio Reports Third Quarter 2019 Operational Highlights and Financial Results
11.12.2019
Iveric Bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled